ArticleMedical oncology (Northwood, London, England)2024

ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma.

Ling Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.